U.S., Sept. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07174011) titled 'Evaluation of the Efficacy and Safety of Oral Roflumilast Versus Intralesional Corticosteroids Injection (ILCs) in the Treatment of Alopecia Areata' on Sept. 08.
Brief Summary: Evaluation of the Efficacy and Safety of a drug called Oral Roflumilast versus Intralesional Corticosteroids Injection (ILCs) in the Treatment of Alopecia Areata.
Study Start Date: Jan. 12
Study Type: INTERVENTIONAL
Condition:
Alopecia
Alopecia Areata
Intervention:
DRUG: Roflumilast
Phosphodiesterase-4 (PDE4) inhibitor assigned to arm A
DRUG: intralesional steroid
intralesional injection of corticosteroid
Recruitment Status: COMPLETED
Sponsor: Cai...